EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
A PHASE3 clinical study on Stroke, Acute Ischemic, this trial is completed. The trial is conducted by Second Affiliated Hospital, School of Medicine, Zhejiang University and has accumulated 7 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Jan 2025 — Sep 2025 [monthly]
Completed PHASE3
-
Sep 2024 — Jan 2025 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Mar 2023 — Jul 2024 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Sep 2022 — Mar 2023 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2022 — Sep 2022 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Second Affiliated Hospital, School of Medicine, Zhejiang University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Anji, China , Botou, China , Dongyang, China , Haiyan, China , Hangzhou, China , Huzhou, China , Jiashan, China , Jiaxing, China , Jinhua, China , Longyan, China and 10 more locations